Assembly Biosciences, Inc.NASDAQ
Jul. 14, 2014, 9:12 AM
- Ventrus Biosciences (NASDAQ:VTUS) shareholders approve the issuance of common stock for the merger with Assembly Pharmaceuticals. The transaction was effective at 5 pm on July 11, 2014. Ventrus shareholders also approved a 1-for-5 reverse stock split and the change of corporate name to Assembly Biosciences. It will begin trading under the symbol "ASMB" today.